FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2214449837> ?p ?o ?g. }

• W2214449837 endingPage "218" @default.
• W2214449837 startingPage "211" @default.
• W2214449837 abstract "VIM-producing Klebsiella pneumoniae isolates are usually associated with high MICs to carbapenems. Preclinical studies investigating the pharmacokinetic–pharmacodynamic (PK-PD) characteristics of carbapenems against these isolates are lacking. The in vitro antibacterial activity of meropenem against one WT and three VIM-producing K. pneumoniae clinical isolates (median MICs 0.031, 8, 16 and 128 mg l− 1) was studied in a dialysis-diffusion PK-PD model and verified in a thigh infection neutropenic animal model by testing selected strains and exposures. The in vitro PK-PD target associated with bactericidal activity was estimated and the target attainment for different dosing regimens was calculated with Monte Carlo analysis. The in vitro model was correlated with the in vivo data, with log10CFU/ml reduction of < 1 for the VIM-producing (MIC 16 mg l− 1) and >2 for the WT (MIC 0.031 mg l− 1) isolates, with %f T >MIC 25 and 100 %, respectively. The in vitro bactericidal activity for all isolates was associated with 40 % f T>MIC and attained in >90 % of cases with the standard 1 g q8 0.5 h infusion dosing regimen only for isolates with MICs up to 1 mg l− 1. For isolates with MICs of 2–8 mg l− 1, prolonged infusion regimens (4 h infusion q8 or 2 h infusion q4) of standard (1 g) and higher (2 g) doses or continuous infusion regimens (3–6 g) are required. For isolates with a MIC of 16 mg l− 1 the unconventional dosing regimen of 2 g as 2 h infusion q4 or 12 g continuous infusion will be required. Prolonged and continuous infusion regimens of meropenem may increase efficacy against VIM-producing K. pneumoniae isolates." @default.
• W2214449837 created "2016-06-24" @default.
• W2214449837 creator A5007875944 @default.
• W2214449837 creator A5008265333 @default.
• W2214449837 creator A5015376605 @default.
• W2214449837 creator A5038285556 @default.
• W2214449837 creator A5047745235 @default.
• W2214449837 creator A5048004383 @default.
• W2214449837 creator A5049685699 @default.
• W2214449837 creator A5070960213 @default.
• W2214449837 date "2016-03-01" @default.
• W2214449837 modified "2023-10-17" @default.
• W2214449837 title "Pharmacokinetic–pharmacodynamic modelling of meropenem against VIM-producing Klebsiella pneumoniae isolates: clinical implications" @default.
• W2214449837 cites W1550111394 @default.
• W2214449837 cites W1852292778 @default.
• W2214449837 cites W1978397220 @default.
• W2214449837 cites W1988702241 @default.
• W2214449837 cites W1993045657 @default.
• W2214449837 cites W200041438 @default.
• W2214449837 cites W2012172825 @default.
• W2214449837 cites W2022638019 @default.
• W2214449837 cites W2031219407 @default.
• W2214449837 cites W2042164350 @default.
• W2214449837 cites W2048067067 @default.
• W2214449837 cites W2071583935 @default.
• W2214449837 cites W2076110457 @default.
• W2214449837 cites W2108473817 @default.
• W2214449837 cites W2113319277 @default.
• W2214449837 cites W2117508830 @default.
• W2214449837 cites W2133916602 @default.
• W2214449837 cites W2137432209 @default.
• W2214449837 cites W2139037525 @default.
• W2214449837 cites W2143150107 @default.
• W2214449837 cites W2145069900 @default.
• W2214449837 cites W2146535783 @default.
• W2214449837 cites W2148103762 @default.
• W2214449837 cites W2156446002 @default.
• W2214449837 cites W2165111961 @default.
• W2214449837 cites W2165839757 @default.
• W2214449837 doi "https://doi.org/10.1099/jmm.0.000214" @default.
• W2214449837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26697851" @default.
• W2214449837 hasPublicationYear "2016" @default.
• W2214449837 type Work @default.
• W2214449837 sameAs 2214449837 @default.
• W2214449837 citedByCount "11" @default.
• W2214449837 countsByYear W22144498372016 @default.
• W2214449837 countsByYear W22144498372017 @default.
• W2214449837 countsByYear W22144498372018 @default.
• W2214449837 countsByYear W22144498372019 @default.
• W2214449837 countsByYear W22144498372020 @default.
• W2214449837 countsByYear W22144498372021 @default.
• W2214449837 countsByYear W22144498372022 @default.
• W2214449837 countsByYear W22144498372023 @default.
• W2214449837 crossrefType "journal-article" @default.
• W2214449837 hasAuthorship W2214449837A5007875944 @default.
• W2214449837 hasAuthorship W2214449837A5008265333 @default.
• W2214449837 hasAuthorship W2214449837A5015376605 @default.
• W2214449837 hasAuthorship W2214449837A5038285556 @default.
• W2214449837 hasAuthorship W2214449837A5047745235 @default.
• W2214449837 hasAuthorship W2214449837A5048004383 @default.
• W2214449837 hasAuthorship W2214449837A5049685699 @default.
• W2214449837 hasAuthorship W2214449837A5070960213 @default.
• W2214449837 hasBestOaLocation W22144498371 @default.
• W2214449837 hasConcept C104317684 @default.
• W2214449837 hasConcept C111113717 @default.
• W2214449837 hasConcept C112705442 @default.
• W2214449837 hasConcept C150903083 @default.
• W2214449837 hasConcept C176947019 @default.
• W2214449837 hasConcept C207001950 @default.
• W2214449837 hasConcept C2777058267 @default.
• W2214449837 hasConcept C2777288759 @default.
• W2214449837 hasConcept C2779375183 @default.
• W2214449837 hasConcept C501593827 @default.
• W2214449837 hasConcept C547475151 @default.
• W2214449837 hasConcept C55493867 @default.
• W2214449837 hasConcept C71924100 @default.
• W2214449837 hasConcept C86803240 @default.
• W2214449837 hasConcept C89423630 @default.
• W2214449837 hasConcept C94665300 @default.
• W2214449837 hasConcept C98274493 @default.
• W2214449837 hasConceptScore W2214449837C104317684 @default.
• W2214449837 hasConceptScore W2214449837C111113717 @default.
• W2214449837 hasConceptScore W2214449837C112705442 @default.
• W2214449837 hasConceptScore W2214449837C150903083 @default.
• W2214449837 hasConceptScore W2214449837C176947019 @default.
• W2214449837 hasConceptScore W2214449837C207001950 @default.
• W2214449837 hasConceptScore W2214449837C2777058267 @default.
• W2214449837 hasConceptScore W2214449837C2777288759 @default.
• W2214449837 hasConceptScore W2214449837C2779375183 @default.
• W2214449837 hasConceptScore W2214449837C501593827 @default.
• W2214449837 hasConceptScore W2214449837C547475151 @default.
• W2214449837 hasConceptScore W2214449837C55493867 @default.
• W2214449837 hasConceptScore W2214449837C71924100 @default.
• W2214449837 hasConceptScore W2214449837C86803240 @default.
• W2214449837 hasConceptScore W2214449837C89423630 @default.
• W2214449837 hasConceptScore W2214449837C94665300 @default.
• W2214449837 hasConceptScore W2214449837C98274493 @default.
• W2214449837 hasIssue "3" @default.

• next